InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Conway Robert e, Director. Director active across 3 companies, notably ARCA biopharma, Inc.. Cumulatively, 6 filings have been logged. Split: 4 buys · 1 sell. Total volume traded: €394k. History available since 5 May 2021. The latest transaction was filed on 23 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Conway Robert e
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
50,000 sharesCommon StockSEC:0001626199-24-000098:0
15,000 shares@ US$10.076918.9% of flowCommon StockSEC:0001626199-21-000130:0
Canonical exit: 22 Dec 2021 (T+90)
15,000 shares@ US$10.076960.6% of flowCommon StockSEC:0001626199-21-000127:0
10,000 shares@ US$9.796639.4% of flowCommon StockSEC:0001626199-21-000120:0
Canonical exit: 20 Dec 2021 (T+90)
10,000 shares@ US$3.194749.5% of flowCommon StockSEC:0001209191-21-032381:0
Canonical exit: 10 Aug 2021 (T+90)
10,000 shares@ US$3.234550.5% of flowCommon StockSEC:0001209191-21-030629:0
Canonical exit: 3 Aug 2021 (T+90)
6 of 6 declarations
About Conway Robert e
Robert E. Conway is a Director of ARCA biopharma, Inc. and ALPINE IMMUNE SCIENCES, INC. He brings extensive experience in corporate governance and strategic decision-making. His role involves overseeing the company's activities and ensuring that shareholder interests are safeguarded. His contribution is essential in guiding these companies within the biopharmaceutical sector.
